Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab

Steffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, Refik Pul, Konstanze Kleinschnitz, Melanie Korsen, Saskia Räuber, Tobias Ruck, Simon Schieferdecker, Alice Grizzel Willison, Orhan Aktas, Christoph Kleinschnitz, Hans-Peter Hartung, Ludwig Kappos, Sven G. Meuth

Open source

DOI: 10.1212/nxi.0000000000200104
Published: 2023-05
Container: Neurology Neuroimmunology & Neuroinflammation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1212/nxi.0000000000200104,
  title = {Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab},
  author = {Steffen Pfeuffer and Leoni Rolfes and Jens Ingwersen and Refik Pul and Konstanze Kleinschnitz and Melanie Korsen and Saskia Räuber and Tobias Ruck and Simon Schieferdecker and Alice Grizzel Willison and Orhan Aktas and Christoph Kleinschnitz and Hans-Peter Hartung and Ludwig Kappos and Sven G. Meuth},
  year = {2023},
  journal = {Neurology Neuroimmunology \&amp; Neuroinflammation},
  doi = {10.1212/nxi.0000000000200104},
  url = {https://doi.org/10.1212/nxi.0000000000200104}
}

RIS

TY  - JOUR
TI  - Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab
AU  - Steffen Pfeuffer
AU  - Leoni Rolfes
AU  - Jens Ingwersen
AU  - Refik Pul
AU  - Konstanze Kleinschnitz
AU  - Melanie Korsen
AU  - Saskia Räuber
AU  - Tobias Ruck
AU  - Simon Schieferdecker
AU  - Alice Grizzel Willison
AU  - Orhan Aktas
AU  - Christoph Kleinschnitz
AU  - Hans-Peter Hartung
AU  - Ludwig Kappos
AU  - Sven G. Meuth
PY  - 2023
JO  - Neurology Neuroimmunology &amp; Neuroinflammation
DO  - 10.1212/nxi.0000000000200104
UR  - https://doi.org/10.1212/nxi.0000000000200104
ER  -

APA

Pfeuffer, S., Rolfes, L., Ingwersen, J., Pul, R., Kleinschnitz, K., Korsen, M., Räuber, S., Ruck, T., Schieferdecker, S., Willison, A. G., Aktas, O., Kleinschnitz, C., Hartung, H., Kappos, L., & Meuth, S. G. (2023). Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology Neuroimmunology & Neuroinflammation. https://doi.org/10.1212/nxi.0000000000200104

Source records

crossref · retrieved 2026-09-27T02:10:58.517Z